Image

https://www.youtube.com/watch?v=3ARdU_FVAgA Orkambi is a combination therapy for treatment of cystic fibrosis. The FDA approval for the therapy was announced on July 2nd, 2015. This is Kate Marshall’s Orkambi testimony before the Open Public Hearing OPH portion of the May 12, 2015 Pulmonary-Allergy Drugs Advisory Committee…

According to the Cystic Fibrosis Foundation: About 70,000 people are living with cystic fibrosis worldwide; In the United States alone: About 30,000 people are living with cystic fibrosis; Approximately 1,000 new cases of CF are diagnosed each year; More than 75 percent of people with CF are diagnosed…

Orkambi (lumacaftor/ivacaftor) For Cystic Fibrosis Ex-vivo Lung Perfusion Technology Opens New Possibilities In One Of The Most Problematic Areas Of Lung Transplant Surgery Galapagos Announces Advancement of GLPG2665 for Triple Combination Treatment for Cystic Fibrosis Patients …

Usually celebrities use their power to promote public awareness and raise help for causes close to their hearts. Read more about #CF here: https://bit.ly/1QltnFs Read more about Celine Dion’s commitment to the #CF cause here: https://bit.ly/1QW1e88…

Follow the North American Cystic Fibrosis Conference livestream here: https://bit.ly/1L1YIM6   Broadcast Schedule Information Thursday – 10/08/2015 10:00AM – 11:45AM MST >>W06: CLIN: Epidemiology of CF >>W08: NRS: Implementing Infection Prevention and Control Guidelines: Successes & Challenges >>W09: SW/PSYCH: Implementation of Mental Health Screening: Strategies & Successes Thursday –…